EP Patent

EP1827438B2 — Piperazin derivatives for inhibiting human stearoyl-coa-desaturase

Assigned to Xenon Pharmaceuticals Inc · Expires 2014-12-10 · 11y expired

What this patent protects

Patent listed against Velsipity.

Drugs covered by this patent

Velsipity (Etrasimod Arginine) · Pfizer Inc.

Patent Metadata

Patent number: EP1827438B2
Jurisdiction: EP
Classification: —
Expires: 2014-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Xenon Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.